This document discusses how Phase 1 clinical materials can be produced in non-GMP facilities using InstantGMP, an electronic manufacturing system. It outlines FDA guidance for Phase 1 GMP which defines necessary quality control procedures and documentation. InstantGMP allows non-GMP facilities to meet these requirements by providing a comprehensive electronic batch record system that streamlines production and ensures compliance. It automatically documents the entire process and permits remote access.